// App-Quantinova.ai

4933 : In Situ analysis of FGFR2 RNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients

Researchers

Presenter

  • Yasutoshi Kuboki

Principal Investigators

  • Christoph A. Schatz

  • Sabine Jabusch

  • Karl Koechert

  • Janine Feng

  • Sabine Wittemer-Rump

  • Karl Ziegelbauer

  • Thomas Krahn

  • Akiko Nagatsuma

  • Atsushi Ochiai

Medical Centers

  • National Cancer Center Hospital, Tokyo, Japan

  • Bayer Pharma AG, Berlin, Germany

  • Ventana Medical Systems, Tucson, AZ

Locations

  • United States

  • Germany

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Gastric Cancer

  • Solid malignancies

  • Diffuse idiopathic skeletal hyperostosis

Biomarkers

  • Fibroblast Growth Factor Receptor 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A